{"id":1312,"date":"2018-09-28T16:45:49","date_gmt":"2018-09-28T14:45:49","guid":{"rendered":"http:\/\/lallianse.com\/site\/?p=1312"},"modified":"2018-09-28T16:45:49","modified_gmt":"2018-09-28T14:45:49","slug":"advicenne-receives-approval-for-marketing-authorization-for-adv6209-in-pediatric-moderate-sedation","status":"publish","type":"post","link":"https:\/\/lallianse.com\/site\/advicenne-receives-approval-for-marketing-authorization-for-adv6209-in-pediatric-moderate-sedation\/","title":{"rendered":"Advicenne receives approval for Marketing Authorization for ADV6209 in Pediatric Moderate Sedation"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb3.7.1&Prime; custom_padding=\u00a0\u00bb0|0px|0|0px|false|false\u00a0\u00bb][et_pb_row custom_padding=\u00a0\u00bb0|0px|0|0px|false|false\u00a0\u00bb _builder_version=\u00a0\u00bb3.7.1&Prime;][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb3.0.47&Prime; parallax=\u00a0\u00bboff\u00a0\u00bb parallax_method=\u00a0\u00bbon\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb3.7.1&Prime; text_font=\u00a0\u00bb||||||||\u00a0\u00bb text_orientation=\u00a0\u00bbjustified\u00a0\u00bb custom_margin=\u00a0\u00bb||10px|\u00a0\u00bb]<\/p>\n<p>Advicenne receives approval for Marketing Authorization for\u00a0ADV6209 in Pediatric Moderate Sedation<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=\u00a0\u00bbhttp:\/\/advicenne.com\/project\/advicenne-receives-approval-for-marketing-authorization-for-adv6209-in-pediatric-moderate-sedation\/\u00a0\u00bb url_new_window=\u00a0\u00bbon\u00a0\u00bb button_text=\u00a0\u00bbRead the press release\u00a0\u00bb button_alignment=\u00a0\u00bbright\u00a0\u00bb _builder_version=\u00a0\u00bb3.7.1&Prime; custom_button=\u00a0\u00bbon\u00a0\u00bb button_text_size=\u00a0\u00bb16px\u00a0\u00bb button_font=\u00a0\u00bb||||||||\u00a0\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Advicenne annonce la pr\u00e9sentation des r\u00e9sultats d\u2019une \u00e9tude  comparant ADV7103  au  traitement  de  r\u00e9f\u00e9rence  chez des  patients  atteints  d\u2019ATRd.<\/p>\n","protected":false},"author":1,"featured_media":578,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[8],"tags":[],"jetpack_featured_media_url":"https:\/\/lallianse.com\/site\/wp-content\/uploads\/2018\/07\/bloc2-produitphare.jpg","_links":{"self":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts\/1312"}],"collection":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/comments?post=1312"}],"version-history":[{"count":3,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts\/1312\/revisions"}],"predecessor-version":[{"id":1315,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts\/1312\/revisions\/1315"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/media\/578"}],"wp:attachment":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/media?parent=1312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/categories?post=1312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/tags?post=1312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}